These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 20144305)

  • 21. An additional measurement of glycated albumin can help prevent missed diagnosis of diabetes in Chinese population.
    He X; Ying L; Ma X; Shen Y; Su H; Peng J; Wang Y; Bao Y; Zhou J; Jia W
    Clin Chim Acta; 2017 Dec; 475():188-192. PubMed ID: 29061312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentosidine plasma levels and relation with metabolic control in diabetic patients.
    Lapolla A; Reitano R; Baccarin L; Sartore G; Plebani M; Fedele D
    Horm Metab Res; 2005 Apr; 37(4):252-6. PubMed ID: 15952087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin.
    Kisugi R; Kouzuma T; Yamamoto T; Akizuki S; Miyamoto H; Someya Y; Yokoyama J; Abe I; Hirai N; Ohnishi A
    Clin Chim Acta; 2007 Jul; 382(1-2):59-64. PubMed ID: 17482589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Rare Case of Variant Hemoglobin (Hb Yahata) Suspected Based on Inconsistent Plasma Glucose and HbA1c Levels.
    Iizuka K; Mizuno M; Niwa H; Takeda J
    Intern Med; 2015; 54(14):1771-5. PubMed ID: 26179534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concordance the hemoglobin glycation index with glycation gap using glycated albumin in patients with type 2 diabetes.
    Kim MK; Jeong JS; Kwon HS; Baek KH; Song KH
    J Diabetes Complications; 2017 Jul; 31(7):1127-1131. PubMed ID: 28487124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Cleary PA; Braffett BH; Orchard T; Lyons TJ; Maynard J; Cowie C; Gubitosi-Klug RA; Way J; Anderson K; Barnie A; Villavicencio S;
    Diabetes Technol Ther; 2013 Jun; 15(6):466-74. PubMed ID: 23882708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1 diabetes.
    Matsumoto H; Murase-Mishiba Y; Yamamoto N; Sugitatsu-Nakatsukasa S; Shibasaki S; Sano H; Terasaki J; Imagawa A; Hanafusa T
    Intern Med; 2012; 51(11):1315-21. PubMed ID: 22687835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
    Basta G; Sironi AM; Lazzerini G; Del Turco S; Buzzigoli E; Casolaro A; Natali A; Ferrannini E; Gastaldelli A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4628-34. PubMed ID: 16926247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications.
    Chiarelli F; de Martino M; Mezzetti A; Catino M; Morgese G; Cuccurullo F; Verrotti A
    J Pediatr; 1999 Apr; 134(4):486-91. PubMed ID: 10190925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-α levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial.
    Houjeghani S; Kheirouri S; Faraji E; Jafarabadi MA
    Nutr Res; 2018 Jan; 49():96-106. PubMed ID: 29420997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Kinetic Model for Glucose Levels and Hemoglobin A1c Provides a Novel Tool for Individualized Diabetes Management.
    Xu Y; Dunn TC; Ajjan RA
    J Diabetes Sci Technol; 2021 Mar; 15(2):294-302. PubMed ID: 31910672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
    Farhan SS; Hussain SA
    Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ratio of estimated average glucose to fasting plasma glucose level is superior to glycated albumin, hemoglobin A1c, fructosamine, and GA/A1c ratio for assessing β-cell function in childhood diabetes.
    Lee JE; Lee JW; Fujii T; Fujii N; Choi JW
    Biomed Res Int; 2014; 2014():370790. PubMed ID: 25013775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral glucose tolerance test does not affect degree of hemoglobin glycation as measured by routine assay.
    Gilliéron N; Hemmerle A; Lung T; Sakem B; Risch L; Risch M; Nydegger UE
    Ann Endocrinol (Paris); 2020 Dec; 81(6):545-550. PubMed ID: 33278381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
    Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
    Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
    Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
    Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring of early and advanced glycation in relation to the occurrence of microvascular complications in children and adolescents with type 1 diabetes mellitus.
    Kostolanská J; Jakus V; Barák L
    Physiol Res; 2009; 58(4):553-561. PubMed ID: 18657005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced glycation end products are associated with arterial stiffness in type 1 diabetes.
    Llauradó G; Ceperuelo-Mallafré V; Vilardell C; Simó R; Gil P; Cano A; Vendrell J; González-Clemente JM
    J Endocrinol; 2014 Jun; 221(3):405-13. PubMed ID: 24681829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced Glycation End Products Are Associated with Diabetes Status and Physical Functions in Patients with Cardiovascular Disease.
    Hirai T; Fujiyoshi K; Yamada S; Matsumoto T; Kikuchi J; Ishida K; Ishida M; Yamaoka-Tojo M; Inomata T; Shigeta K; Tojo T
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.